SCHEMBL669659

SCHEMBL669659

NCO[PH](=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL9463540 0.89
Oxalic Acid SCHEMBL3176058 0.89 GLRA1 (0.32)
SCHEMBL28937205 0.77
SCHEMBL1878100 0.75
SCHEMBL27643432 0.73
SCHEMBL28646468 0.73
SCHEMBL669658 0.72
SCHEMBL220514 0.72
SCHEMBL96445 0.72
Ethylenediamine SCHEMBL23064434 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 299 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717354-A1 ION EXCHANGE REGENERATION METHOD ImerTech SAS (FR) 2026-04-01 EP claimed
CN-119192234-A Aminomethylphosphonic acid ammonium compound, birefringent crystal thereof, and preparation method and application thereof 滨州医学院 2024-12-27 CN claimed
CN-105531121-B Fabric print media 惠普发展公司,有限责任合伙企业 2020-10-16 CN claimed
CN-108570072-B Method for synthesizing phosphonic acid modified graphene or phosphonate modified graphene 新乡学院 2020-02-07 CN claimed
US-10239329-B2 Fabric print medium HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2019-03-26 US claimed
EP-3046775-B1 FABRIC PRINT MEDIUM HEWLETT PACKARD DEVELOPMENT CO LP (US) 2018-03-07 EP claimed
EP-3046775-A1 FABRIC PRINT MEDIUM Hewlett-Packard Development Company, L.P. (US) 2016-07-27 EP claimed
US-20160159107-A1 FABRIC PRINT MEDIUM HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2016-06-09 US claimed
WO-2015041666-A1 FABRIC PRINT MEDIUM HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2015-03-26 WO claimed
EP-1135511-B1 PHOSPHONATE METABOLIZING PLANTS MONSANTO TECHNOLOGY LLC (US) 2009-06-17 EP claimed
JP-3937445-B2 2007-06-27 JP claimed
EP-1563003-A1 METHOD FOR IMPROVING FIRE RESISTANCE OF POLYETHYLENE TUBING AND POLYETHYLENE TUBING MANUFACTURED ACCORDING TO SAID METHOD Lögstör Rör A/S (DK) 2005-08-17 EP claimed
WO-2004029138-A1 METHOD FOR IMPROVING FIRE RESISTANCE OF POLYETHYLENE TUBING AND POLYETHYLENE TUBING MANUFACTURED ACCORDING TO SAID METHOD LØGSTØR RØR A/S (DK) 2004-04-08 WO claimed
CN-1113654-C Compounds and pharmaceutical compositions containing them ELESONKROGI AG (CH) 2003-07-09 CN claimed
CN-1193913-A Compounds and pharmaceutical compositions containing them SYMPHAR SA (CH) 1998-09-23 CN claimed
US-5702611-A MIXTURE OF A CHELATE ION EXCHANGE RESINS AND AN ANIONIC EXCHANGE RESIN SHIPLEY COMPANY, L.L.C. (US) 1997-12-30 US claimed
EP-0701622-A1 PROCESS FOR PREPARING GLYOXYLIC ACID/DIALKYL AMINOMETHYLPHOSPHONATE MIXTURES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-03-20 EP claimed
WO-1994028155-A1 PROCESS FOR PREPARING GLYOXYLIC ACID/DIALKYL AMINOMETHYLPHOSPHONATE MIXTURES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1994-12-08 WO claimed
US-5213691-A Barium sulfate scale, acrylic polymers with pendant phosphonate groups NALCO CHEMICAL COMPANY (US) 1993-05-25 US claimed
JP-61042528-A None JP disclosed
JP-61044945-A None JP disclosed
JP-1094948-A None JP disclosed
EP-4717354-A1 ION EXCHANGE REGENERATION METHOD ImerTech SAS (FR) 2026-04-01 EP disclosed
US-20260049039-A1 MICROFIBRILLATED CELLULOSE AS RHEOLOGY MODIFIER IN HIGH IONIC STRENGTH AGRICULTURAL FORMULATIONS AMVAC CHEMICAL CORP (US) 2026-02-19 US disclosed
US-20260049309-A1 REGULATION OF ACTIVITY OF RNAI MOLECULES NOVO NORDISK AS (DE) 2026-02-19 US disclosed
CN-119192234-B Aminomethylphosphonic acid ammonium compound, birefringent crystal thereof, and preparation method and application thereof 滨州医学院 2025-09-30 CN disclosed
EP-4619523-A1 STAT3 TARGETING OLIGONUCLEOTIDES AND USES THEREOF Novo Nordisk A/S (DK) 2025-09-24 EP disclosed
US-20250290071-A1 STAT3 TARGETING OLIGONUCLEOTIDES AND USES THEREOF NOVO NORDISK A/S (DK) 2025-09-18 US disclosed
US-12378165-B2 Pesticide formulation comprising MFC as rheology modifier AMVAC CHEMICAL CORPORATION (US) 2025-08-05 US disclosed
US-20250128993-A1 AGRICULTURAL ADJUVANT COMPRISING MICROFIBRILLATED CELLULOSE AMVAC CHEMICAL CORPORATION 2025-04-24 US disclosed
US-20250122500-A1 RNAi OLIGONUCLEOTIDE CONJUGATES NOVO NORDISK A/S (DK) 2025-04-17 US disclosed
WO-2025054459-A1 RNAI OLIGONUCLEOTIDE CONJUGATES DICERNA PHARMACEUTICALS, INC. (US) 2025-03-13 WO disclosed
EP-4493695-A2 COMBINATION OF STAT3 TARGETING OLIGONUCLEOTIDES AND PD-L1 INHIBITORS Dicerna Pharmaceuticals, Inc. (US) 2025-01-22 EP disclosed
CN-119192234-A Aminomethylphosphonic acid ammonium compound, birefringent crystal thereof, and preparation method and application thereof 滨州医学院 2024-12-27 CN disclosed
CN-119192234-A Aminomethylphosphonic acid ammonium compound, birefringent crystal thereof, and preparation method and application thereof 滨州医学院 2024-12-27 CN disclosed
WO-2024233864-A2 GALNAC-CONJUGATED RNAI OLIGONUCLEOTIDES DICERNA PHARMACEUTICALS, INC. (US) 2024-11-14 WO disclosed
EP-4426839-A1 LIPID CONJUGATION FOR TARGETING ASTROCYTES OF THE CENTRAL NERVOUS SYSTEM Dicerna Pharmaceuticals, Inc. (US) 2024-09-11 EP disclosed
EP-4426432-A1 LIPID CONJUGATION FOR TARGETING OLIGODENDROCYTES OF THE CENTRAL NERVOUS SYSTEM Dicerna Pharmaceuticals, Inc. (US) 2024-09-11 EP disclosed
US-20240287512-A1 LIPID CONJUGATION FOR TARGETING NEURONS OF THE CENTRAL NERVOUS SYSTEM NOVO NORDISK A/S (DK) 2024-08-29 US disclosed
EP-3214109-B1 POLYCARBONATE RESIN, MOLDED ARTICLE AND OPTICAL FILM MITSUBISHI CHEM CORP (JP) 2024-08-21 EP disclosed
US-12049431-B2 Agricultural adjuvant comprising microfibrillated cellulose AMVAC Chemical Corporation (Subsidiary of American Vanguard Corporation) (US) 2024-07-30 US disclosed
WO-2024107993-A1 STAT3 TARGETING OLIGONUCLEOTIDES AND USES THEREOF DICERNA PHARMACEUTICALS, INC. (US) 2024-05-23 WO disclosed
CN-116063610-B Polymer microsphere and preparation method and application thereof 中国石油化工股份有限公司 2024-05-07 CN disclosed
US-20240124875-A1 RNAI CONJUGATES AND USES THEREOF NOVO NORDISK A/S (DK) 2024-04-18 US disclosed
EP-4347820-A1 COMPOSITIONS AND METHODS FOR INHIBITING MITOCHONDRIA AMIDOXIME REDUCING COMPONENT 1 (MARC1) EXPRESSION Novo Nordisk A/S (DK) 2024-04-10 EP disclosed
EP-4337773-A1 LIPID CONJUGATION FOR TARGETING NEURONS OF THE CENTRAL NERVOUS SYSTEM Dicerna Pharmaceuticals, Inc. (US) 2024-03-20 EP disclosed
WO-2024040041-A1 REGULATION OF ACTIVITY OF RNAI MOLECULES DICERNA PHARMACEUTICALS, INC. (US) 2024-02-22 WO disclosed
EP-4301376-A1 RNAI CONJUGATES AND USES THEREOF Dicerna Pharmaceuticals, Inc. (US) 2024-01-10 EP disclosed
CN-114369328-B Low-smoke aging-resistant crosslinked elastomer and preparation method thereof 宁波聚泰新材料科技有限公司 2023-12-19 CN disclosed
US-20230357773-A1 OLIGONUCLEOTIDE TREATMENT OF HEPATITIS B PATIENTS HOFFMANN-LA ROCHE INC. 2023-11-09 US disclosed
US-20230340490-A1 COMPOSITIONS AND METHODS FOR INHIBITING MITOCHONDRIA AMIDOXIME REDUCING COMPONENT 1 (MARC1) EXPRESSION NOVO NORDISK A/S (DK) 2023-10-26 US disclosed
WO-2023178141-A2 COMBINATION OF STAT3 TARGETING OLIGONUCLEOTIDES AND PD-L1 INHIBITORS DICERNA PHARMACEUTICALS, INC. (US) 2023-09-21 WO disclosed
US-20230265528-A1 METHODS FOR TARGETED DEPLETION OF NUCLEIC ACIDS JUMPCODE GENOMICS INC (US) 2023-08-24 US disclosed
EP-4196604-A2 METHODS FOR TARGETED DEPLETION OF NUCLEIC ACIDS Jumpcode Genomics, Inc. (US) 2023-06-21 EP disclosed
EP-4192955-A1 OLIGONUCLEOTIDE TREATMENT OF HEPATITIS B PATIENTS F. Hoffmann-La Roche AG (CH) 2023-06-14 EP disclosed
US-11655473-B2 Compositions and methods for inhibiting mitochondria amidoxime reducing component 1 (MARC1) expression NOVO NORDISK A/S (DK) 2023-05-23 US disclosed
WO-2023081822-A1 LIPID CONJUGATION FOR TARGETING OLIGODENDROCYTES OF THE CENTRAL NERVOUS SYSTEM DICERNA PHARMACEUTICALS, INC. (US) 2023-05-11 WO disclosed
WO-2023081823-A1 LIPID CONJUGATION FOR TARGETING ASTROCYTES OF THE CENTRAL NERVOUS SYSTEM DICERNA PHARMACEUTICALS, INC. (US) 2023-05-11 WO disclosed
WO-2023081500-A2 RNAi OLIGONUCLEOTIDE CONJUGATES DICERNA PHARMACEUTICALS, INC. (US) 2023-05-11 WO disclosed
CN-116063610-A Polymer microsphere and preparation method and application thereof 中国石油化工股份有限公司 2023-05-05 CN disclosed
US-20230079931-A1 MICROFIBRILLATED CELLULOSE AS RHEOLOGY MODIFIER IN HIGH IONIC STRENGTH AGRICULTURAL FORMULATIONS AMVAC CHEMICAL CORP (US) 2023-03-16 US disclosed
US-20230042451-A1 COMPOSITIONS AND METHODS FOR INHIBITING MITOCHONDRIA AMIDOXIME REDUCING COMPONENT 1 (MARC1) EXPRESSION NOVO NORDISK A/S (DK) 2023-02-09 US disclosed
WO-2022248665-A1 COMPOSITIONS AND METHODS FOR INHIBITING MITOCHONDRIA AMIDOXIME REDUCING COMPONENT 1 (MARC1) EXPRESSION NOVO NORDISK A/S (DK) 2022-12-01 WO disclosed
WO-2022240952-A1 LIPID CONJUGATION FOR TARGETING NEURONS OF THE CENTRAL NERVOUS SYSTEM DICERNA PHARMACEUTICALS, INC. (US) 2022-11-17 WO disclosed
WO-2022187622-A1 RNAI CONJUGATES AND USES THEREOF DICERNA PHARMACEUTICALS, INC. (US) 2022-09-09 WO disclosed
CN-111491674-B Composition comprising a thiol-, alkene-and phosphonic acid-containing compound as adhesion-improving primer 生物医学键合有限公司 2022-08-23 CN disclosed
US-20220186229-A1 METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF CYP27A1 DICERNA PHARMACEUTICALS, INC. 2022-06-16 US disclosed
WO-2022035950-A2 METHODS FOR TARGETED DEPLETION OF NUCLEIC ACIDS Jumpcode Genomics, Inc. (US) 2022-02-17 WO disclosed
WO-2022029209-A1 OLIGONUCLEOTIDE TREATMENT OF HEPATITIS B PATIENTS F. HOFFMANN-LA ROCHE AG (CH) 2022-02-10 WO disclosed
EP-3908661-A1 METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF CYP27A1 Dicerna Pharmaceuticals, Inc. (US) 2021-11-17 EP disclosed
CN-113166485-A Silanol composition and method of use 3M创新有限公司 2021-07-23 CN disclosed
CN-107580557-B Printable media 惠普发展公司,有限责任合伙企业 2020-12-01 CN disclosed
CN-105531121-B Fabric print media 惠普发展公司,有限责任合伙企业 2020-10-16 CN disclosed
EP-3233510-B1 FABRIC PRINT MEDIUM HEWLETT PACKARD DEVELOPMENT CO LP (US) 2020-09-09 EP disclosed
WO-2020167593-A1 METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF CYP27A1 DICERNA PHARMACEUTICALS, INC. (US) 2020-08-20 WO disclosed
CN-111491674-A Composition comprising a thiol-, alkene-and phosphonic acid-containing compound as adhesion-improving primer 生物医学键合有限公司 2020-08-04 CN disclosed
CN-107208359-B Fabric print media 惠普发展公司,有限责任合伙企业 2020-05-19 CN disclosed
CN-111087688-A Anti-blushing flame-retardant polypropylene ribbon and preparation method thereof 南京聚隆科技股份有限公司 2020-05-01 CN disclosed
EP-3119611-B1 PRINTABLE MEDIA HEWLETT PACKARD DEVELOPMENT CO (US) 2020-04-29 EP disclosed
US-20200095217-A1 HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE GLAXOSMITHKLINE IP NO 2 LTD (GB) 2020-03-26 US disclosed
CN-108570072-B Method for synthesizing phosphonic acid modified graphene or phosphonate modified graphene 新乡学院 2020-02-07 CN disclosed
US-10464363-B2 Printable media HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2019-11-05 US disclosed
EP-3265321-B1 PRINTABLE MEDIA HEWLETT PACKARD DEVELOPMENT CO (US) 2019-10-09 EP disclosed
US-10357987-B2 Fabric print medium HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2019-07-23 US disclosed
US-10239329-B2 Fabric print medium HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2019-03-26 US disclosed
EP-3022063-B1 PRINTABLE MEDIUM HEWLETT PACKARD DEVELOPMENT CO (US) 2018-12-26 EP disclosed
CN-105377569-B Printable media 惠普发展公司,有限责任合伙企业 2018-10-19 CN disclosed
US-10081707-B2 Polycarbonate resin, molded article, and optical film MITSUBISHI CHEMICAL CORPORATION (JP) 2018-09-25 US disclosed
US-9993490-B2 Phosphonic acid compounds and screening method THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2018-06-12 US disclosed
US-20180079246-A1 PRINTABLE MEDIA HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2018-03-22 US disclosed
EP-3046775-B1 FABRIC PRINT MEDIUM HEWLETT PACKARD DEVELOPMENT CO LP (US) 2018-03-07 EP disclosed
EP-3003729-B1 FABRIC PRINT MEDIUM HEWLETT PACKARD DEVELOPMENT CO LP (US) 2018-02-21 EP disclosed
US-20180015763-A1 FABRIC PRINT MEDIUM HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2018-01-18 US disclosed
EP-3265321-A1 PRINTABLE MEDIA Hewlett-Packard Development Company, L.P. (US) 2018-01-10 EP disclosed
US-9855781-B2 Printable medium HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2018-01-02 US disclosed
EP-2903994-B1 ORGANOPHOSPHORUS COMPOUNDS FOR FLAME RETARDANT POLYURETHANE FOAMS DOW GLOBAL TECHNOLOGIES LLC (US) 2017-11-22 EP disclosed
WO-2017196354-A1 FABRIC PRINT MEDIA HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2017-11-16 WO disclosed
EP-3233510-A1 FABRIC PRINT MEDIUM Hewlett-Packard Development Company, L.P. (US) 2017-10-25 EP disclosed
US-9782768-B2 Method for removing heavy metals from an aqueous solution with cross-linked copolymers KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2017-10-10 US disclosed
US-9770931-B2 Fabric print medium HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2017-09-26 US disclosed
EP-3214109-A1 POLYCARBONATE RESIN, MOLDED ARTICLE AND OPTICAL FILM Mitsubishi Chemical Corporation (JP) 2017-09-06 EP disclosed
US-20170204220-A1 POLYCARBONATE RESIN, MOLDED ARTICLE, AND OPTICAL FILM MITSUBISHI CHEMICAL CORPORATION (JP) 2017-07-20 US disclosed
US-20170202863-A1 PHOSPHONIC ACID COMPOUNDS AND SCREENING METHOD THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2017-07-20 US disclosed
US-9707790-B2 Printable media HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2017-07-18 US disclosed
US-20170113215-A1 METHOD FOR REMOVING HEAVY METALS FROM AN AQUEOUS SOLUTION WITH CROSS-LINKED COPOLYMERS KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2017-04-27 US disclosed
US-20170057269-A1 PRINTABLE MEDIA HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2017-03-02 US disclosed
EP-3119611-A1 PRINTABLE MEDIA Hewlett-Packard Development Company, L.P. (US) 2017-01-25 EP disclosed
EP-1539766-B1 CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2016-12-21 EP disclosed
US-9480979-B1 Cross-linked copolymers and methods thereof KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2016-11-01 US disclosed
EP-3046775-A1 FABRIC PRINT MEDIUM Hewlett-Packard Development Company, L.P. (US) 2016-07-27 EP disclosed
US-20160159107-A1 FABRIC PRINT MEDIUM HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2016-06-09 US disclosed
EP-2643391-B1 METHODS OF PROCESSING HIGH SERVICE TEMPERATURE HYDROCARBON GELS COMMSCOPE TECHNOLOGIES LLC (US) 2016-06-08 EP disclosed
US-20160152060-A1 PRINTABLE MEDIUM HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2016-06-02 US disclosed
EP-3022063-A1 PRINTABLE MEDIUM Hewlett-Packard Development Company, L.P. (US) 2016-05-25 EP disclosed
EP-3003729-A1 FABRIC PRINT MEDIUM Hewlett-Packard Development Company, L.P. (US) 2016-04-13 EP disclosed
US-20160059606-A1 FABRIC PRINT MEDIUM HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2016-03-03 US disclosed
WO-2016014539-A1 PHOSPHONIC ACID COMPOUNDS AND SCREENING METHOD THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-01-28 WO disclosed
WO-2015142313-A1 PRINTABLE MEDIA HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2015-09-24 WO disclosed
EP-2904024-A1 POLYURETHANE AND POLYISOCYANURATE RIGID FOAMS SUITABLE FOR ROOFING INSULATION Bayer MaterialScience LLC (US) 2015-08-12 EP disclosed
WO-2015041666-A1 FABRIC PRINT MEDIUM HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2015-03-26 WO disclosed
CN-102007118-B Pyrrolidinone glucokinase activators HOFFMANN LA ROCHE 2014-12-31 CN disclosed
WO-2014055318-A1 POLYURETHANE AND POLYISOCYANURATE RIGID FOAMS SUITABLE FOR ROOFING INSULATION BAYER MATERIALSCIENCE LLC (US) 2014-04-10 WO disclosed
EP-2456767-B1 PYRIDONE GLUCOKINASE ACTIVATORS HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
US-20130131113-A1 PYRIDONE GLUCOKINASE ACTIVATORS HOFFMANN-LA ROCHE INC. (US) 2013-05-23 US disclosed
EP-2582706-A1 3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-C]PYRROLES AS GLUCOKINASE ACTIVATORS F.HOFFMANN-LA ROCHE AG (CH) 2013-04-24 EP disclosed
US-8404172-B2 Methods of processing high service temperature hydrocarbon gels TYCO ELECTRONICS CORPORATION (US) 2013-03-26 US disclosed
US-8258134-B2 Pyridazinone glucokinase activators HOFFMANN-LA ROCHE INC. (US) 2012-09-04 US disclosed
EP-2456767-A1 PYRIDONE GLUCOKINASE ACTIVATORS F. Hoffmann-La Roche AG (CH) 2012-05-30 EP disclosed
US-8178689-B2 Tricyclic compounds HOFFMAN-LA ROCHE INC. (US) 2012-05-15 US disclosed
EP-2274297-B1 PYRROLIDINONE GLUCOKINASE ACTIVATORS HOFFMANN LA ROCHE (CH) 2012-05-09 EP disclosed
WO-2012024233-A2 ZWITTERIONIC LIPIDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-23 WO disclosed
US-20110313002-A1 TRICYCLIC COMPOUNDS SARABU RAMAKANTH (US) 2011-12-22 US disclosed
WO-2011157682-A1 3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-C]PYRROLES AS GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-22 WO disclosed
US-7973219-B2 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-07-05 US disclosed
CN-102007118-A Pyrrolidinone glucokinase activators HOFFMANN LA ROCHE 2011-04-06 CN disclosed
US-20110021570-A1 PYRIDONE GLUCOKINASE ACTIVATORS HAYNES NANCY-ELLEN 2011-01-27 US disclosed
WO-2011009845-A1 PYRIDONE GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2011-01-27 WO disclosed
EP-2274297-A1 PYRROLIDINONE GLUCOKINASE ACTIVATORS F. Hoffmann-La Roche AG (CH) 2011-01-19 EP disclosed
US-7842808-B2 calcitonin gene-related peptide receptors antagonists such as 4-(2-Oxo-2,3-dihydro-benzoimidazol-1-yl)-piperidine-1-carboxylic acid[2-(1,4-dioxa-8-aza-spiro [4.5]dec-8-yl)-1-(1H-indol-5-ylmethyl)-2-oxo-ethyl]-amide, used for treating headaches, pain, hot flashes or respiratory system disorders BRISTOL-MYERS SQUIBB COMPANY (US) 2010-11-30 US disclosed
EP-1762588-B1 Coating with fire retardant properties for surfaces and method for the preparation thereof LOGSTOR AS (DK) 2010-11-24 EP disclosed
US-7772244-B2 Therapeutic agents for the treatment of migraine BRISTOL-MYERS SQUIBB COMPANY (US) 2010-08-10 US disclosed
US-20100184597-A1 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants NAKAJIMA HIROKI 2010-07-22 US disclosed
US-7754732-B2 Spirocyclic anti-migraine compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-13 US disclosed
US-7741327-B2 Pyrrolidinone glucokinase activators HOFFMANN-LA ROCHE INC. (US) 2010-06-22 US disclosed
US-7649015-B2 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds GILEAD SCIENCES, INC. (US) 2010-01-19 US disclosed
US-20090264434-A1 PYRIDAZINONE GLUCOKINASE ACTIVATORS BERTHEL STEVEN JOSEPH 2009-10-22 US disclosed
US-20090264445-A1 PYRROLIDINONE GLUCOKINASE ACTIVATORS BERTHEL STEVEN JOSEPH 2009-10-22 US disclosed
WO-2009127546-A1 PYRROLIDINONE GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2009-10-22 WO disclosed
US-20090247488-A1 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS CANNIZZARO CARINA 2009-10-01 US disclosed
EP-1728871-B1 Particle mediated transformation of soybean with glyphosate selection MONSANTO TECHNOLOGY LLC (US) 2009-09-16 EP disclosed
US-20090227543-A1 PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY CANNIZZARO CARINA 2009-09-10 US disclosed
EP-1664046-B1 AZA-QUINOLINOL PHOSPHONATE INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES INC (US) 2009-06-17 EP disclosed
EP-1135511-B1 PHOSPHONATE METABOLIZING PLANTS MONSANTO TECHNOLOGY LLC (US) 2009-06-17 EP disclosed
CN-101410120-A Anti-inflammatory phosphonate compounds GILEAD SCIENCES INC (US) 2009-04-15 CN disclosed
US-7485777-B2 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-02-03 US disclosed
US-20090029939-A1 Pre-organized tricyclic integrase inhibitor compounds GILEAD SCIENCES, INC. 2009-01-29 US disclosed
US-7470724-B2 Phosphonate compounds having immuno-modulatory activity GILEAD SCIENCES, INC. (US) 2008-12-30 US disclosed
US-7462721-B2 Aza-quinolinol phosphonate integrase inhibitor compounds GILEAD SCIENCES, INC. (US) 2008-12-09 US disclosed
US-7462608-B2 Non nucleoside reverse transcriptase inhibitors GILEAD SCIENCES, INC. (US) 2008-12-09 US disclosed
US-7432261-B2 Anti-inflammatory phosphonate compounds GILEAD SCIENCES, INC. (US) 2008-10-07 US disclosed
US-20080153783-A1 Pyrimidyl Phosphonate Antiviral Compounds and Methods of Use GILEAD SCIENCES, INC. (US) 2008-06-26 US disclosed
EP-1689493-A4 CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2008-04-23 EP disclosed
US-20080076738-A1 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds GILEAD SCIENCES, INC. 2008-03-27 US disclosed
US-7314883-B2 Anti-migraine treatments BRISTOL-MYERS SQUIBB COMPANY (US) 2008-01-01 US disclosed
EP-1509537-B9 CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH GILEAD SCIENCES INC (US) 2007-11-14 EP disclosed
US-20070232600-A1 ANTI-MIGRAINE TREATMENTS BRISTOL-MYERS SQUIBB COMPANY 2007-10-04 US disclosed
CN-101041669-A Non nucleoside reverse transcriptase inhibitors GILEAD SCIENCES INC (US) 2007-09-26 CN disclosed
US-20070190523-A1 Method and compositions for identifying anti-hiv therapeutic compounds GILEAD SCIENCES, INC. 2007-08-16 US disclosed
US-20070185007-A1 Aza-quinolinol phosphonate integrase inhibitor compounds JIN HAOLUN 2007-08-09 US disclosed
US-7253180-B2 Pre-organized tricyclic integrase inhibitor compounds GILEAD SCIENCES, INC. (US) 2007-08-07 US disclosed
EP-1509537-B1 CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH GILEAD SCIENCES INC (US) 2007-07-18 EP disclosed
US-20070148093-A1 Non-terminal method of identifying anti-migraine compounds BRISTOL-MYERS SQUIBB COMPANY 2007-06-28 US disclosed
US-20070149503-A1 ANTI-MIGRAINE SPIROCYCLES BRISTOL-MYERS SQUIBB COMPANY 2007-06-28 US disclosed
US-20070149502-A1 SPIROCYCLIC ANTI-MIGRAINE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY 2007-06-28 US disclosed
CN-1972929-A Heterocyclic CGRP antagonists for the treatment of migraine BRISTOL MYERS SQUIBB CO (US) 2007-05-30 CN disclosed
US-7220862-B2 Calcitonin gene related peptide receptor antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-22 US disclosed
US-20070059468-A1 Graft coating for pre-insulated pipe LOGSTOR A/S (DK) 2007-03-15 US disclosed
EP-1575486-A4 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES INC (US) 2007-02-28 EP disclosed
EP-1742642-A2 PHOSPHONATE ANALOGS OF HIV INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2007-01-17 EP disclosed
US-20070010489-A1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds GILEAD SCIENCES, INC. 2007-01-11 US disclosed
EP-1730137-A1 HETEROCYCLIC CGRP ANTAGONISTS FOR THE TREATMENT OF MIGRAINE Bristol-Myers Squibb Company (US) 2006-12-13 EP disclosed
EP-1728871-A2 Particle mediated transformation of soyabean with glyphosate selection Monsanto Technology, LLC (US) 2006-12-06 EP disclosed
EP-1711476-A2 PYRIMIDYL PHOSPHONATE ANTIVIRAL COMPOUNDS AND METHODS OF USE GILEAD SCIENCES, INC. (US) 2006-10-18 EP disclosed
EP-1711617-A1 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTICS COMPOUNDS GILEAD SCIENCES, INC. (US) 2006-10-18 EP disclosed
US-20060217410-A1 Pre-organized tricyclic integrase inhibitor compounds GILEAD SCIENCES, INC. 2006-09-28 US disclosed
WO-2005064008-A9 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES INC (US) 2006-09-28 WO disclosed
US-20060199788-A1 Anti-inflammatory phosphonate compounds GILEAD SCIENCES, INC. 2006-09-07 US disclosed
EP-1689493-A1 CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS Bristol-Myers Squibb Pharma Company (US) 2006-08-16 EP disclosed
EP-1280850-B1 COATING COMPOSITION FOR POLYETHYLENE LOGSTAR ROR AS (DK) 2006-06-21 EP disclosed
US-20060128692-A1 Non nucleoside reverse transcriptase inhibitors GILEAD SCIENCES, INC (US) 2006-06-15 US disclosed
EP-1664046-A1 AZA-QUINOLINOL PHOSPHONATE INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2006-06-07 EP disclosed
EP-1663254-A2 ANTI-INFLAMATORY PHOSPHONATE CONJUGATES GILEAD SCIENCES, INC. (US) 2006-06-07 EP disclosed
US-20060116356-A1 Phosphonate analogs of HIV integrase inhibitor compounds GILEAD SCIENCES, INC. 2006-06-01 US disclosed
US-20060115815-A1 Method and compositions for identifying anti-hiv therapeutic compounds GILEAD SCIENCES, INC. 2006-06-01 US disclosed
EP-1068341-B1 PARTICLE MEDIATED TRANSFORMATION OF SOYBEAN WITH GLYPHOSATE SELECTION MONSANTO TECHNOLOGY LLC (US) 2006-05-31 EP disclosed
US-20060035866-A1 Phosphonate compounds having immuno-modulatory activity GILEAD SCIENCES, INC. 2006-02-16 US disclosed
EP-1620445-A2 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2006-02-01 EP disclosed
EP-1620110-A2 IMMUNOMODULATOR PHOSPHONATE CONJUGATES GILEAD SCIENCES, INC. (US) 2006-02-01 EP disclosed
US-20050282839-A1 Pyrimidyl phosphonate antiviral compounds and methods of use GILEAD SCIENCES, INC. 2005-12-22 US disclosed
WO-2005117904-A2 PHOSPHONATE ANALOGS OF HIV INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-12-15 WO disclosed
US-20050257284-A1 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants SUMITOMO CHEMICAL CO., LTD. 2005-11-17 US disclosed
US-20050239054-A1 Method and compositions for identifying anti-HIV therapeutic compounds GILEAD SCIENCES. INC. 2005-10-27 US disclosed
WO-2005095383-A1 HETEROCYCLIC CGRP ANTAGONISTS FOR THE TREATMENT OF MIGRAINE BRISTOL-MYERS SQUIBB COMPANY (US) 2005-10-13 WO disclosed
US-RE38825-E1 Genes encoding a glyphosate oxidoreductase enzyme; useful in producing transformed bacteria and plants which degrade glyphosate herbicide; crop plants which are tolerant to glyphosate herbicide MONSANTO TECHNOLOGY LLC (US) 2005-10-11 US disclosed
US-20050215576-A1 Novel therapeutic agents for the treatment of migraine BRISTOL-MYERS SQUIBB COMPANY 2005-09-29 US disclosed
US-20050209197-A1 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds GILEAD SCIENCES, INC. 2005-09-22 US disclosed
EP-1575486-A2 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-09-21 EP disclosed
US-20050197320-A1 Non nucleoside reverse transcriptase inhibitors GILEAD SCIENCES, INC. 2005-09-08 US disclosed
CN-1656109-A Non-nucleoside reverse transcriptase inhibitors GILEAD SCIENCES INC (US) 2005-08-17 CN disclosed
WO-2005070901-A2 PYRIMIDYL PHOSPHONATE ANTIVIRAL COMPOUNDS AND METHODS OF USE GILEAD SCIENCES, INC. (US) 2005-08-04 WO disclosed
EP-1558613-A2 PRE-ORGANIZED TRICYCLIC INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-08-03 EP disclosed
WO-2005065779-A1 CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-07-21 WO disclosed
WO-2005064008-A1 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-07-14 WO disclosed
US-20050137199-A1 Inhibition of HiV integrase compounds GILEAD SCIENCES, INC. 2005-06-23 US disclosed
EP-1539766-A1 CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS Bristol-Myers Squibb Company (US) 2005-06-15 EP disclosed
US-6906245-B1 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-06-14 US disclosed
WO-2005028478-A1 AZA-QUINOLINOL PHOSPHONATE INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-03-31 WO disclosed
EP-1509537-A2 CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH GILEAD SCIENCES, INC. (US) 2005-03-02 EP disclosed
EP-1501841-A2 NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS GILEAD SCIENCES, INC. (US) 2005-02-02 EP disclosed
WO-2004111261-A1 CARBON-PHOSPHORUS OR CARBON-ARSENIC BOND-CONTAINING MOIETIES SUITABLE FOR LINKING TO ANTIMICROBIAL AGENT UNISEARCH LIMITED (AU) 2004-12-23 WO disclosed
WO-2004100960-A2 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS GILEAD SCIENCES, INC. (US) 2004-11-25 WO disclosed
WO-2004096818-A2 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2004-11-11 WO disclosed
WO-2004096236-A2 IMMUNOMODULATOR PHOSPHONATE CONJUGATES GILEAD SCIENCES, INC. (US) 2004-11-11 WO disclosed
US-20040204397-A1 Calcitonin gene related peptide receptor antagonists BRISTOL-MYERS SQUIBB COMPANY 2004-10-14 US disclosed
US-6783865-B2 FIRE RESISTANCE; CAPABLE OF RETAINING POST-MANUFACTURING PAINT, MARKINGS, OR ADHESIVES LOGSTOR ROR A/S (DK) 2004-08-31 US disclosed
US-20040167124-A1 Pre-organized tricyclic integrase inhibitor compounds GILEAD SCIENCES, INC. 2004-08-26 US disclosed
US-20040157804-A1 Pre-organized tricyclic integrase inhibitor compounds GILEAD SCIENCES, INC. 2004-08-12 US disclosed
US-20040121316-A1 Method and compositions for identifying anti-HIV therapeutic compounds GILEAD SCIENCES, INC. 2004-06-24 US disclosed
WO-2004035576-A2 PRE-ORGANIZED TRICYCLIC INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2004-04-29 WO disclosed
WO-2004035577-A2 PRE-ORGANIZED TRICYCLIC INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2004-04-29 WO disclosed
US-20040063735-A1 Calcitonin gene related peptide receptor antagonists BRISTOL-MYERS SQUIBB COMPANY 2004-04-01 US disclosed
US-6701842-B2 Process for the treatment of an erasable lithographic printing plate MAN ROLAND DRUCKMASCHINEN AG (DE) 2004-03-09 US disclosed
WO-2003104236-A1 CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-18 WO disclosed
WO-2003090691-A2 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2003-11-06 WO disclosed
WO-2003090690-A2 CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH GILEAD SCIENCES, INC. (US) 2003-11-06 WO disclosed
WO-2003091264-A2 NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS GILEAD SCIENCES, INC. (US) 2003-11-06 WO disclosed
CN-1113654-C Compounds and pharmaceutical compositions containing them ELESONKROGI AG (CH) 2003-07-09 CN disclosed
CN-1090665-C Magnetic recording binder containing aminoalkylphosphonate salt MORTON INT INC (US) 2002-09-11 CN disclosed
US-20020096074-A1 Process for the treatment of an erasable lithographic printing plate MAN ROLAND DRUCKMASCHINEN AG 2002-07-25 US disclosed
CN-1353873-A Composite body suitable for utilization as lithium ion battery BASF AG (DE) 2002-06-12 CN disclosed
EP-0536330-B1 GLYPHOSATE TOLERANT PLANTS MONSANTO TECHNOLOGY LLC (US) 2002-02-27 EP disclosed
EP-0980404-A4 IMIDE-FREE AND MIXED AMIDE/IMIDE THERMAL SYNTHESIS OF POLYASPARTATE UNIV SOUTH ALABAMA (US) 2001-12-12 EP disclosed
EP-1068341-A1 PARTICLE MEDIATED TRANSFORMATION OF SOYBEAN WITH GLYPHOSATE SELECTION Monsanto Technology LLC (US) 2001-01-17 EP disclosed
US-6169176-B1 SYNTHESIZING OLIGONUCLEOTIDES HAVING A BACKBONE OF ALKYL OR ALKOXY THIOUREA LINKAGES; ANTISENSE AND GENE THERAPY AGENTS WITH INCREASED AFFINITY AND NUCLEASE RESISTANCE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-01-02 US disclosed
US-6136965-A Deoxynucleic alkyl and alkoxy thiourea compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-10-24 US disclosed
CN-1255137-A Method for preparing formylphosphonic acid MONSANTO CO (US) 2000-05-31 CN disclosed
EP-0980404-A1 IMIDE-FREE AND MIXED AMIDE/IMIDE THERMAL SYNTHESIS OF POLYASPARTATE UNIVERSITY OF SOUTH ALABAMA (US) 2000-02-23 EP disclosed
US-5981691-A THERMAL SYNTHESIS OF POLYASPARTATE WITHOUT FORMATION OF THE INTERMEDIATE POLYSUCCINIMIDE; HEATING SALT OF ASPARTIC ACID WITH POLYAMINE UNIVERSITY OF SOUTH ALABAMA (US) 1999-11-09 US disclosed
WO-1999051759-A1 PARTICLE MEDIATED TRANSFORMATION OF SOYBEAN WITH GLYPHOSATE SELECTION MONSANTO COMPANY (US) 1999-10-14 WO disclosed
EP-0948507-A1 HYDROGENATION OF CYANOPHOSPHONATE DERIVATIVES MONSANTO COMPANY (US) 1999-10-13 EP disclosed
US-5914451-A HERBICIDE TOLERANCE MONSANTO COMPANY (US) 1999-06-22 US disclosed
US-5905163-A REDUCTION OF CYANO GROUP BY CATALYTIC HYDROGENATION MONSANTO COMPANY (US) 1999-05-18 US disclosed
US-5866334-A Determination and identification of active compounds in a compound library GENZYME CORPORATION (US) 1999-02-02 US disclosed
EP-0647937-B1 Binder for magnetic media MINNESOTA MINING & MFG (US) 1999-01-27 EP disclosed
CN-1041694-C Aminolkylphosphonic acid containing ligands attached to solid supports for removal of metalions. UNIV BRIGHAM YOUNG (US) 1999-01-20 CN disclosed
WO-1998047964-A1 IMIDE-FREE AND MIXED AMIDE/IMIDE THERMAL SYNTHESIS OF POLYASPARTATE UNIVERSITY OF SOUTH ALABAMA (US) 1998-10-29 WO disclosed
CN-1193913-A Compounds and pharmaceutical compositions containing them SYMPHAR SA (CH) 1998-09-23 CN disclosed
WO-1998029423-A1 HYDROGENATION OF CYANOPHOSPHONATE DERIVATIVES MONSANTO COMPANY (US) 1998-07-09 WO disclosed
US-5776760-A Glyphosate tolerant plants MONSANTO COMPANY (US) 1998-07-07 US disclosed
EP-0754238-A4 DETERMINATION AND IDENTIFICATION OF ACTIVE COMPOUNDS IN A COMPOUND LIBRARY PHARMAGENICS INC (US) 1998-01-28 EP disclosed
US-5670326-A NUCLEIC ACIDS, PEPTIDES PHARMAGENICS, INC. (US) 1997-09-23 US disclosed
EP-0754238-A1 DETERMINATION AND IDENTIFICATION OF ACTIVE COMPOUNDS IN A COMPOUND LIBRARY PHARMAGENICS, INC. (US) 1997-01-22 EP disclosed
EP-0701622-A1 PROCESS FOR PREPARING GLYOXYLIC ACID/DIALKYL AMINOMETHYLPHOSPHONATE MIXTURES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-03-20 EP disclosed
US-5491029-A Magnetic recording medium having a binder composition comprising phosphonated polyurethane and a vinyl chloride copolymer with ammonium functionalities MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-02-13 US disclosed
EP-0641354-A4 OLIGONUCLEOTIDES HAVING AMINOHYDROCARBON PHOSPHONATE MOIETIES. PHARMAGENICS INC (US) 1996-01-10 EP disclosed
CN-1113513-A Magnetic recording binder containing aminoalkylphosphonate salt MORTON INT INC (US) 1995-12-20 CN disclosed
WO-1995031572-A1 AMINOHYDROCARBON PHOSPHONATE OLIGONUCLEOTIDES AND USES THEREFOR PHARMGENICS, INC. (US) 1995-11-23 WO disclosed
US-5463175-A Gene encoding a glyphosate oxidoreductase enzyme; genetic engineered double-stranded DNA molecule MONSANTO COMPANY (US) 1995-10-31 US disclosed
WO-1995027072-A1 DETERMINATION AND IDENTIFICATION OF ACTIVE COMPOUNDS IN A COMPOUND LIBRARY PHARMAGENICS, INC. (US) 1995-10-12 WO disclosed
EP-0647937-A1 Binder for magnetic media MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-04-12 EP disclosed
CN-1101303-A Process for preparing weakly-basic anion exchangers and reagents suitable for this purpose BAYER AG (DE) 1995-04-12 CN disclosed
EP-0641354-A1 OLIGONUCLEOTIDES HAVING AMINOHYDROCARBON PHOSPHONATE MOIETIES PHARMAGENICS, INC. (US) 1995-03-08 EP disclosed
WO-1994028155-A1 PROCESS FOR PREPARING GLYOXYLIC ACID/DIALKYL AMINOMETHYLPHOSPHONATE MIXTURES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1994-12-08 WO disclosed
CN-1088485-A Be used to remove the part on the solid carrier of being stated from that contains the aminoalkyl phosphonic acids of metal ion UNIV BRIGHAM YOUNG (US) 1994-06-29 CN disclosed
US-5312910-A Plant gene and DNA molecule encoding the synthase; using planted crop seed or plant which is glyphosate tolerant as a result of chimeric gene insertion to selectively control weeds in field containing seed or plant; N-phosphonomethylglycine MONSANTO COMPANY (US) 1994-05-17 US disclosed
WO-1993011148-A1 OLIGONUCLEOTIDES HAVING AMINOHYDROCARBON PHOSPHONATE MOIETIES PHARMAGENICS, INC. (US) 1993-06-10 WO disclosed
US-5213691-A Barium sulfate scale, acrylic polymers with pendant phosphonate groups NALCO CHEMICAL COMPANY (US) 1993-05-25 US disclosed
EP-0536330-A1 GLYPHOSATE TOLERANT PLANTS MONSANTO COMPANY (US) 1993-04-14 EP disclosed
CN-1069976-A Hexanaphthene and tetrahydropyran derivatives HOFFMANN LA ROCHE (CH) 1993-03-17 CN disclosed
US-5188642-A Planting crop seeds inserted with chimeric gene encoding mutant 5-enolpyruvylshikimate-3-phosphate synthase(EPSPS); transgenic plants allow use of glyphosate herbicide to kill weeds without killing the crop MONSANTO COMPANY (US) 1993-02-23 US disclosed
US-5145783-A Herbicide tolerant plants MONSANTO COMPANY (US) 1992-09-08 US disclosed
EP-0318392-B1 N-(VINBLASTINOYL-23)DERIVATIVES OF 1-AMINO METHYLPHOSPHONIC ACIDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ADIR ET COMPAGNIE (FR) 1992-04-15 EP disclosed
WO-1992000377-A1 GLYPHOSATE TOLERANT PLANTS MONSANTO COMPANY (US) 1992-01-09 WO disclosed
US-4971908-A GENETIC ENGINEERING TO PRODUCE A GENE CODE ENZYME MONSANTO COMPANY (US) 1990-11-20 US disclosed
US-4940835-A Chimeric plant gene that confers resistance to the herbicide glyphosate; allows use of herbicide on plant crops to kill weeds without harming the crop MONSANTO COMPANY (US) 1990-07-10 US disclosed
EP-0350172-A2 Process for preparing an aminomethylphosphonic chelating resin THE DOW CHEMICAL COMPANY (US) 1990-01-10 EP disclosed
EP-0318392-A1 N-(vinblastinoyl-23)derivatives of 1-amino methylphosphonic acids, processes for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1989-05-31 EP disclosed
JP-H0194948-A FLUORINE ION REMOVAL METHOD AGENCY OF IND SCIENCE & TECHNOL 1989-04-13 JP disclosed
EP-0293358-A2 Glyphosate tolerant 5-enolpyruvyl-3-phosphoshikimate synthase MONSANTO COMPANY (US) 1988-11-30 EP disclosed
EP-0068978-B1 PROCESS FOR THE PREPARATION OF (THIENYL-2)- AND (THIENYL-3)-2 ETHYLAMINE DERIVATIVES, AND PRODUCTS SO OBTAINED ELF SANOFI (FR) 1986-09-03 EP disclosed
JP-S6144945-A PREPARATION OF FLAME-RESISTANT PHENOLIC RESIN ASAHI DENKA KOGYO KK 1986-03-04 JP disclosed
JP-S6142528-A PRODUCTION OF PHOSPHORUS-CONTAINING POLYURETHANE MATERIAL ASAHI DENKA KOGYO KK 1986-03-01 JP disclosed
EP-0069622-B1 PROCESS FOR THE PREPARATION OF BETA-CYCLO-SUBSTITUTED ETHYL AMINES, AND PRODUCTS SO OBTAINED SANOFI S.A. (FR) 1985-09-18 EP disclosed
EP-0068978-A1 Process for the preparation of (thienyl-2)- and (thienyl-3)-2 ethylamine derivatives, and products so obtained ELF SANOFI (FR) 1983-01-05 EP disclosed
US-4237024-A USING AN AQUEOUS SOLUTION OF SODIUM HYPOCHLORITE CERTIFIED CHEMICALS, INC. (US) 1980-12-02 US disclosed
US-4184991-A TREATING WATER WITH A BENZOTRIAZOLE AND AN ACRYLIC ESTER POLYMER ZIMMITE CORPORATION (US) 1980-01-22 US disclosed
US-4102799-A PHOSPHATE-FREE, CONTAINS CITRATE COMPOUND AND INORGANIC BUILDER SALTS SUCH AS SILICATES, CARBONATES, AND SULFATES COLGATE-PALMOLIVE COMPANY (US) 1978-07-25 US disclosed
US-4013813-A AMINOALKYLPHOSPHONIC ACID ESTER-BASED TEXTILE FIRE RETARDANTS LEBLANC RESEARCH CORPORATION (US) 1977-03-22 US disclosed
US-3935162-A Dialkyl aromatic amidomethyl phosphonate flame retardants HOOKER CHEMICALS & PLASTICS CORPORATION (US) 1976-01-27 US disclosed
US-3935162-A Dialkyl aromatic amidomethyl phosphonate flame retardants HOOKER CHEMICALS & PLASTICS CORPORATION (US) 1976-01-27 US disclosed